Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $64.5B
1-Year Est. Return 42.76%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+42.76%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$75.8B
AUM Growth
+$582M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,038
New
Increased
Reduced
Closed

Top Buys

1 +$633M
2 +$487M
3 +$419M
4
META icon
Meta Platforms (Facebook)
META
+$345M
5
KO icon
Coca-Cola
KO
+$257M

Top Sells

1 +$1.36B
2 +$900M
3 +$583M
4
NVDA icon
NVIDIA
NVDA
+$335M
5
NFLX icon
Netflix
NFLX
+$320M

Sector Composition

1 Technology 21.72%
2 Healthcare 15.16%
3 Consumer Discretionary 11.8%
4 Communication Services 10.53%
5 Financials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CREG icon
3826
Smart Powerr
CREG
$25.8M
-2,020
CRGX
3827
DELISTED
CARGO Therapeutics
CRGX
-323,400
CRMD icon
3828
CorMedix
CRMD
$580M
-152,200
CRNC icon
3829
Cerence
CRNC
$357M
-311,117
CRVS icon
3830
Corvus Pharmaceuticals
CRVS
$1.57B
-165,188
CSGS icon
3831
CSG Systems International
CSGS
$2.26B
-37,312
CUBE icon
3832
CubeSmart
CUBE
$8.79B
-134,688
CVRX icon
3833
CVRx
CVRX
$149M
-14,000
DAL icon
3834
Delta Air Lines
DAL
$45.4B
-514,900
DBEF icon
3835
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$8.72B
-60,095
DBI icon
3836
Designer Brands
DBI
$329M
-239,730
DEM icon
3837
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.6B
-16,473
DFAI icon
3838
Dimensional International Core Equity Market ETF
DFAI
$14.4B
-9,200
DFAX icon
3839
Dimensional World ex US Core Equity 2 ETF
DFAX
$11.2B
-11,800
DFEM icon
3840
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
$7.93B
-8,600
DFIC icon
3841
Dimensional International Core Equity 2 ETF
DFIC
$13.3B
-16,800
EFSC icon
3842
Enterprise Financial Services Corp
EFSC
$2.23B
-20,700
EFX icon
3843
Equifax
EFX
$22.7B
-85,995
ELEV
3844
DELISTED
Elevation Oncology
ELEV
-165,829
ELV icon
3845
Elevance Health
ELV
$74.2B
-53,573
EMB icon
3846
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$16B
-223,600
EMLC icon
3847
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$5.02B
-613,300
ENGN icon
3848
enGene Holdings
ENGN
$666M
-11,400
ENOV icon
3849
Enovis
ENOV
$1.25B
-75,967
ENVB icon
3850
Enveric Biosciences
ENVB
$2.81M
-3,084